Skip to content

Lantheus Holdings LNTH Free cash flow

Free cash flow at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$112M+14.3%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Guardant Health logo
Guardant HealthGH
Revvity logo
RevvityRVTY
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$377.3M+1.2%
Gross profit$230.9M-2.9%
Operating income$81.3M-20.3%
Net income$118.4M+62.3%
EPS (diluted)$1.80+76.5%

Balance sheet

See full
Cash & equivalents$500.3M-46.8%
Total debt$627.9M+1.8%
Total equity$1.2B+4.1%
Total assets$2.3B+14.2%

Cash flow

See full
Operating cash flow$125.1M+16.3%
CapEx$3.2M-63.0%

Valuation

See full
Market cap$6.76B-26.3%
Enterprise value$6.89B-20.5%
P/E24.2×-10.2×
P/S4.4×-1.6×

Profitability

See full
Gross margin60.5%-3.6pp
Operating margin18.8%-10.7pp
Net margin18%+0.7pp
FCF margin24.4%-6.4pp

Returns & leverage

See full
Return on equity23.5%-1.7pp
Debt / equity0.5×0.0×
Current ratio2.8×-2.9×

Where this comes from

Calculated from Lantheus Holdings’s reported figures.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lantheus Holdings's free cash flow?
Lantheus Holdings (LNTH) reported free cash flow of $121.9M in Q1 2026.
How has Lantheus Holdings's free cash flow changed year-over-year?
Lantheus Holdings's free cash flow increased by 23.3% year-over-year, from $98.85M to $121.9M.
What is the long-term trend for Lantheus Holdings's free cash flow?
Over 2 years (2021 to 2025), Lantheus Holdings's free cash flow has grown at a 156.3% compound annual growth rate (CAGR), from $53.92M to $354.05M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.